A protein kinase C-dependent activity modulates retinoic acid-induced transcription.

Mol Endocrinol

INSERM-CJF 92-03, Faculte de Medecine de Lille, France.

Published: December 1993

The retinoic acid receptors (RARs) and retinoid X receptors, which are members of the nuclear receptor family, mediate the effects of vitamin A derivatives on cellular growth and differentiation. The protein kinase C isozyme family also controls these processes in response to extracellular stimuli. We have investigated the relationship between these two signal transducing pathways using gene transfer techniques. We show that selective inhibition of protein kinase C (PKC) and its depletion by prolonged treatment with 12-O-tetradecanoylphorbol-13-acetate lead to the loss of ligand-dependent transcription of an RA-inducible promoter. The effect of the depletion in cellular PKC could be counteracted by overexpression of PKC alpha and is directly correlated to the loss of the DNA-binding activity of complexes containing the human RAR alpha (hRAR alpha). Indirect immunofluorescence studies demonstrated an altered subcellular localization of hRAR alpha. However, direct in vitro phosphorylation of hRAR alpha by PKC diminished its ability to form heterodimeric or homodimeric complexes on a retinoic acid response element, suggesting that the DNA-binding capacity of hRAR alpha in intact cells is indirectly controlled by a PKC-dependent mechanism. Thus our observations establish a functional link between the PKC and retinoid pathways, which are generally considered to have antagonistic activities on differentiation processes.

Download full-text PDF

Source
http://dx.doi.org/10.1210/mend.7.12.8145770DOI Listing

Publication Analysis

Top Keywords

hrar alpha
16
protein kinase
12
retinoic acid
8
alpha
6
pkc
5
kinase c-dependent
4
c-dependent activity
4
activity modulates
4
modulates retinoic
4
retinoic acid-induced
4

Similar Publications

has a long history of usage as a treatment for metabolic diseases, especially, diabetes mellitus (DM). Thus, we aimed to isolate and evaluate bioactive constituents derived from leaves for the treatment of DM. According to bioassay-guided isolation by column chromatography, eight compounds were obtained from leaves: two phenolic compounds, -coumaric acid () and chlorogenic acid methyl ester (), one stilbene, oxyresveratrol (), two stilbene dimers, macrourin B () and austrafuran C (), one 2-arylbenzofuran, moracin M (), and two Diels-Alder type adducts, mulberrofuran F () and chalcomoracin ().

View Article and Find Full Text PDF

Over the years, great attention has been paid to coumarin derivatives, a set of versatile molecules that exhibit a wide variety of biological activities and have few toxic side effects. In this study, we investigated the antidiabetic potential of 6-formyl umbelliferone (6-FU), a novel furanocoumarin isolated from . Numerous pharmacological activities of 6-FU have been previously reported; however, the mechanism of its antidiabetic activity is unknown.

View Article and Find Full Text PDF

Poncirin, a natural flavanone glycoside present abundantly in many citrus fruits, contains an extensive range of biological activities. However, the antidiabetic mechanism of poncirin is unexplored yet. In this study, we examined the anti-diabetic prospective of poncirin by evaluating its ability to inhibit protein tyrosine phosphatase 1B (PTP1B), α-glucosidase, human recombinant AR (HRAR), rat lens aldose reductase (RLAR), and advanced glycation end-product (AGE) formation (IC = 7.

View Article and Find Full Text PDF

Didymin is a naturally occurring orally active flavonoid glycoside (isosakuranetin 7-O-rutinoside) found in various citrus fruits, which has been previously reported to possess a wide variety of pharmacological activities including anticancer, antioxidant, antinociceptive, neuroprotective, hepatoprotective, inflammatory, and cardiovascular. However, there have not been any reports concerning its anti-diabetic potential until now. Therefore, we evaluated the anti-diabetic potential of didymin via inhibition of α-glucosidase, protein tyrosine phosphatase 1B (PTP1B), rat lens aldose reductase (RLAR), human recombinant AR (HRAR), and advanced glycation end-product (AGE) formation inhibitory assays.

View Article and Find Full Text PDF

In the present study, we investigated the anti-diabetic potential of fucosterol by evaluating the ability of this compound to inhibit rat lens aldose reductase (RLAR), human recombinant aldose reductase (HRAR), protein tyrosine phosphatase 1B (PTP1B), and α-glucosidase. Fucosterol displayed moderate inhibitory activity against RLAR, HRAR, and PTP1B. However, it showed weak or no activity against AGE formation and α-glucosidase.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!